NasdaqGM - Delayed Quote • USD EDAP TMS S.A. (EDAP) Follow Compare 2.1000 -0.1000 (-4.55%) At close: January 10 at 4:00:01 PM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for EDAP 1D 5D -15.66% 1M -5.41% 3M -19.85% 6M -57.49% YTD -3.67% 1Y -60.15% 5Y -50.59% All -77.30% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: EDAP View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations EDAP Appoints Joshua H. Levine to Board of Directors EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer Senti Bio Appoints Fran Schulz to Board of Directors EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis EDAP TMS Third Quarter 2024 Earnings: Misses Expectations Edap TMS SA (EDAP) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amidst Rising Expenses EDAP Reports Third Quarter 2024 Financial Results EDAP to Participate in the 2024 Jefferies London Healthcare Conference